{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T12:01:55Z","timestamp":1789732915140,"version":"4.0.1"},"reference-count":134,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Hepatocellular carcinoma (HCC), a malignancy with high global morbidity and mortality, has therapeutic resistance as a major focus of both clinical and basic research. In recent years, protein post-translational modifications (PTMs), key regulators of intracellular protein function and cell signaling, play critical roles in therapeutic resistance in liver cancer. Current studies indicate that diverse PTMs\u2014including phosphorylation, ubiquitination, acetylation, lactylation, and glycosylation\u2014modulate liver cancer cell responses to chemotherapy, targeted therapy, immunotherapy and local therapies. This review systematically summarizes the molecular mechanisms and common pathways through which PTMs contribute to therapeutic resistance in liver cancer, explores PTM-mediated mechanism underlying tumor persistence and distant recurrence,examines how PTM-targeted strategies may reverse resistance, and discusses the challenges and prospects of these therapeutic approaches in clinical practice. By integrating current research, this review aims to provide a theoretical basis and potential targets for precision therapy of drug-resistant liver cancer, offering novel intervention targets and translational strategies to overcome therapeutic resistance in HCC.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1914652","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:58:40Z","timestamp":1788346720000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Post-translational modification in hepatocellular carcinoma resistance: molecular mechanisms and therapeutic targeting"],"prefix":"10.3389","volume":"17","author":[{"given":"Simin","family":"Feng","sequence":"first","affiliation":[{"name":"Department of Interventional Radiology, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology","place":["Luoyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Luoyang Central Hospital","place":["Luoyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Guo","sequence":"additional","affiliation":[{"name":"Henan Key Laboratory of Cancer Epigenetics, Cancer Institute, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology","place":["Luoyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Xu","sequence":"additional","affiliation":[{"name":"Henan Key Laboratory of Cancer Epigenetics, Cancer Institute, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology","place":["Luoyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailiang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, People\u2019s Hospital of Zhengzhou University, Henan Provincial People\u2019s Hospital","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanzhang","family":"Niu","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology","place":["Luoyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyang","family":"Li","sequence":"additional","affiliation":[{"name":"Henan Key Laboratory of Cancer Epigenetics, Cancer Institute, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology","place":["Luoyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2025.189290","article-title":"Alpha-1 antitrypsin deficiency and primary liver cancers","volume":"1880","author":"Schneider","year":"2025","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1159\/000546574","article-title":"China liver cancer guidelines for the diagnosis and treatment of hepatocellular carcinoma (2024 edition)","volume":"14","author":"Jian","year":"2025","journal-title":"Liver Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2025.101571","article-title":"Hepatocellular carcinoma: Epidemiology, diagnosis and treatment","volume":"7","author":"Ezequiel","year":"2025","journal-title":"JHEP Rep"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1159\/000549355","article-title":"Rechallenge with immune checkpoint inhibitors in patients with hepatocellular carcinoma: A narrative review","author":"Jin","year":"2025","journal-title":"Liver Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1159\/000546138","article-title":"Current perspectives on perioperative combination therapy for hepatocellular carcinoma","volume":"14","author":"Takahiro","year":"2025","journal-title":"Liver Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115561","article-title":"Combating drug resistance in hepatocellular carcinoma: No awareness today, no action tomorrow","volume":"167","author":"Fanbo","year":"2023","journal-title":"BioMed Pharmacother"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.3390\/ijms24032805","article-title":"The roles of epigenetic regulation and the tumor microenvironment in the mechanism of resistance to systemic therapy in hepatocellular carcinoma","volume":"24","author":"Oura","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1133308","article-title":"Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma","volume":"14","author":"Chen","year":"2023","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12575-025-00281-6","article-title":"Mechanisms of drug resistance in hepatocellular carcinoma","volume":"27","author":"Zou","year":"2025","journal-title":"Biol Proced Online"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1240115","article-title":"Post-translational modifications and their implications in cancer","volume":"13","author":"Dutta","year":"2023","journal-title":"Front Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2026.1726574","article-title":"Unveiling the hidden regulators: how post-translational modifications influence the progression and treatment of hepatocellular carcinoma","volume":"16","author":"Shuaiyong","year":"2026","journal-title":"Front Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216758","article-title":"Unleashing the power of immune checkpoints: Post-translational modification of novel molecules and clinical applications","volume":"588","author":"Wang","year":"2024","journal-title":"Cancer Lett"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-023-00633-y","article-title":"Deubiquitinases in cancer","volume":"23","author":"Grant","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/s41392-023-01604-3","article-title":"Combined FOLFOX4 with all-trans retinoic acid versus FOLFOX4 with placebo in treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a randomized, double-blind comparative study","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1038\/s41467-023-38753-6","article-title":"Lysyl oxidase-like 3 restrains mitochondrial ferroptosis to promote liver cancer chemoresistance by stabilizing dihydroorotate dehydrogenase","volume":"14","author":"Zhan","year":"2023","journal-title":"Nat Commun"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1038\/s41467-023-37542-5","article-title":"PRMT3-mediated arginine methylation of IGF2BP1 promotes oxaliplatin resistance in liver cancer","volume":"14","author":"Yunxing","year":"2023","journal-title":"Nat Commun"},{"key":"B17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41389-025-00592-z","article-title":"Dual roles of USP1 in HELLS deubiquitination and SUMOylation drive EMT and FOLFOX-based chemoresistance","volume":"14","author":"Jie","year":"2025","journal-title":"Oncogenesis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2014.170","article-title":"Bcl-2 stabilization by paxillin confers 5-fluorouracil resistance in colorectal cancer","volume":"22","author":"Wu","year":"2015","journal-title":"Cell Death Differ"},{"key":"B19","doi-asserted-by":"publisher","first-page":"8869","DOI":"10.1038\/s41598-025-93029-x","article-title":"USP39\/SMC4 promotes hepatoma cell proliferation and 5-FU resistance","volume":"15","author":"Zhou","year":"2025","journal-title":"Sci Rep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1503490","article-title":"Salidroside enhances 5-fluorouracil sensitivity against hepatocellular carcinoma via YIPF5-induced mitophagy","volume":"15","author":"Sun","year":"2024","journal-title":"Front Pharmacol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07359-9","article-title":"Histone lactylation promotes multidrug resistance in hepatocellular carcinoma by forming a positive feedback loop with PTEN","volume":"16","author":"Yuan","year":"2025","journal-title":"Cell Death Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103869","article-title":"PARK7-driven IGF2BP3-K76 lactylation mediates ferroptosis and HAIC resistance in hepatocellular carcinoma","volume":"87","author":"Zhiwen","year":"2025","journal-title":"Redox Biol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.canlet.2021.06.016","article-title":"Acetylation-induced PCK isoenzyme transition promotes metabolic adaption of liver cancer to systemic therapy","volume":"519","author":"Jing","year":"2021","journal-title":"Cancer Lett"},{"key":"B24","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1186\/s12967-025-06333-5","article-title":"Endogenous protein S100A14 stabilizes glutaminase to render hepatocellular carcinoma resistant to sorafenib","volume":"23","author":"Wang","year":"2025","journal-title":"J Transl Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"4048","DOI":"10.3390\/ijms20164048","article-title":"Sorafenib-induced apoptosis in hepatocellular carcinoma is reversed by SIRT1","volume":"16","author":"Garten","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114402","article-title":"XPO1 intensifies sorafenib resistance by stabilizing acetylation of NPM1 and enhancing epithelial-mesenchymal transition in hepatocellular carcinoma","volume":"160","author":"Zengbin","year":"2023","journal-title":"BioMed Pharmacother"},{"key":"B27","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41420-023-01469-z","article-title":"PLEKHG5 is stabilized by HDAC2-related deacetylation and confers sorafenib resistance in hepatocellular carcinoma","volume":"9","author":"Sha","year":"2023","journal-title":"Cell Death Discov"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106789","article-title":"Upregulation of CSNK1A1 induced by ITGB5 confers to hepatocellular carcinoma resistance to sorafenib in vivo by disrupting the EPS15\/EGFR complex","volume":"192","author":"Gu","year":"2023","journal-title":"Pharmacol Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.62347\/EAFU3015","article-title":"NOTCH1 regulates the DNA damage response and sorafenib resistance by activating ATM in hepatocellular carcinoma","volume":"16","author":"Liu","year":"2024","journal-title":"Am J Transl Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70324","article-title":"USP22 promotes the proliferation and sorafenib resistance of hepatocellular carcinoma cells via its deubiquitinase activity","volume":"15","author":"Wang","year":"2025","journal-title":"Clin Transl Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41419-025-07772-0","article-title":"Targeting USP18 overcomes acquired resistance in hepatocellular carcinoma by regulating NCOA4 deISGylation and ferroptosis","volume":"16","author":"Shengtao","year":"2025","journal-title":"Cell Death Dis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s13046-024-03169-7","article-title":"CCT3\/ACTN4\/TFRC axis protects hepatocellular carcinoma cells from ferroptosis by inhibiting iron endocytosis","volume":"43","author":"Zhu","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.7150\/thno.82132","article-title":"Protein phosphatase 2A-B55\u03b2 mediated mitochondrial p-GPX4 dephosphorylation promoted sorafenib-induced ferroptosis in hepatocellular carcinoma via regulating p53 retrograde signaling","volume":"13","author":"Qian","year":"2023","journal-title":"Theranostics"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s13577-023-00945-z","article-title":"MiR-3677-3p promotes development and sorafenib resistance of hepatitis B-related hepatocellular carcinoma by inhibiting FOXM1 ubiquitination","volume":"36","author":"He","year":"2023","journal-title":"Hum Cell"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.2174\/1568009622666220428111327","article-title":"Resistance of lenvatinib in hepatocellular carcinoma","volume":"22","author":"Guo","year":"2022","journal-title":"Curr Cancer Drug Targets"},{"key":"B36","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.3390\/ijms26094161","article-title":"MicroRNA-142-3p overcomes drug resistance in hepatocellular carcinoma by targeting YES1 and TWF1","volume":"26","author":"Mahboobnia","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2025.101271","article-title":"Exosome-derived lnc-FAM72D-3 promotes lenvatinib resistance by remodeling hepatocellular carcinoma cytoskeleton via MBNL1\/FAK axis","volume":"82","author":"Cao","year":"2025","journal-title":"Drug Resist Update"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-025-01597-9","article-title":"Targeting DDOST improves the efficacy of lenvatinib and immunotherapy in hepatocellular carcinoma","volume":"57","author":"Jun","year":"2025","journal-title":"Exp Mol Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-24-3196","article-title":"CRTC2 forms co-condensates with YTHDF2 that enhance translational efficiency of m6A-modified mRNAs to drive hepatocarcinogenesis and lenvatinib resistance","volume":"85","author":"Meixi","year":"2025","journal-title":"Cancer Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-02282-y","article-title":"N6-methyladenosine-modification of USP15 regulates chemotherapy resistance by inhibiting LGALS3 ubiquitin-mediated degradation via AKT\/mTOR signaling activation pathway in hepatocellular carcinoma","volume":"11","author":"Fang","year":"2025","journal-title":"Cell Death Discov"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2025.101224","article-title":"DTX2 attenuates lenvatinib-induced ferroptosis by suppressing docosahexaenoic acid biosynthesis through HSD17B4-dependent peroxisomal \u03b2-oxidation in hepatocellular carcinoma","volume":"81","author":"Zhongyan","year":"2025","journal-title":"Drug Resist Update"},{"key":"B42","doi-asserted-by":"publisher","first-page":"191","DOI":"10.21037\/jgo-24-737","article-title":"PRMT5 attenuates regorafenib-induced DNA damage in hepatocellular carcinoma cells through symmetric dimethylation of RPL14","volume":"16","author":"Bi","year":"2025","journal-title":"J Gastrointest Oncol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-025-01722-w","article-title":"A ROS-mediated oxidation-O-GlcNAcylation cascade governs ferroptosis","volume":"27","author":"Hemeng","year":"2025","journal-title":"Nat Cell Biol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2025.101274","article-title":"ZNF207-driven PRDX1 lactylation and NRF2 activation in regorafenib resistance and ferroptosis evasion","volume":"82","author":"Yang","year":"2025","journal-title":"Drug Resist Update"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.2147\/JHC.S607656","article-title":"Post-translational modification networks in ferroptosis: Orchestrating defense, drug resistance, and therapeutic opportunities in hepatocellular carcinoma","volume":"13","author":"Jie","year":"2026","journal-title":"J Hepatocell Carcinoma"},{"key":"B46","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13046-023-02659-4","article-title":"FGFR4 and EZH2 inhibitors synergistically induce hepatocellular carcinoma apoptosis via repressing YAP signaling","volume":"42","author":"Yiqi","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1228200","article-title":"Emerging role of deubiquitination modifications of programmed death-ligand 1 in cancer immunotherapy","volume":"14","author":"Jiang","year":"2023","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.3390\/ijms25052939","article-title":"Programmed death ligand 1 regulatory crosstalk with ubiquitination and deubiquitination: Implications in cancer immunotherapy","volume":"25","author":"Kim","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-024-01432-0","article-title":"A STT3A-dependent PD-L1 glycosylation modification mediated by GMPS drives tumor immune evasion in hepatocellular carcinoma","volume":"32","author":"Xinyu","year":"2025","journal-title":"Cell Death Differ"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.115024","article-title":"Targeting USP47 enhances immunotherapy in hepatocellular carcinoma by destabilizing PD-L1","volume":"161","author":"Jiang","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e012230","DOI":"10.1136\/jitc-2025-012230","article-title":"Lactylation-driven MVP upregulation boosts immunotherapy resistance by inhibiting PD-L1 degradation in hepatocellular carcinoma","volume":"13","author":"Shuang","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0000000000001785","article-title":"SENP3-mediated deSUMOylation stabilizes programmed death-ligand 1 to promote immune evasion in hepatocellular carcinoma","volume":"37","author":"Bin","year":"2026","journal-title":"Anticancer Drugs"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e007529","DOI":"10.1136\/jitc-2023-007529","article-title":"CDK5 destabilizes PD-L1 via chaperon-mediated autophagy to control cancer immune surveillance in hepatocellular carcinoma","volume":"11","author":"Zhang","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e001377","DOI":"10.1136\/jitc-2020-001377","article-title":"2,5-dimethylcelecoxib improves immune microenvironment of hepatocellular carcinoma by promoting ubiquitination of HBx-induced PD-L1","volume":"8","author":"Chen","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adp7302","article-title":"Palmitoylation of TIM-3 promotes immune exhaustion and restrains antitumor immunity","volume":"9","author":"Zhang","year":"2024","journal-title":"Sci Immunol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.bbrc.2021.05.034","article-title":"The N-linked glycosylations of TIGIT Asn32 and Asn101 facilitate PVR\/TIGIT interaction","volume":"562","author":"Lin","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1016\/j.cell.2025.02.014","article-title":"Ligand-induced ubiquitination unleashes LAG3 immune checkpoint function by hindering membrane sequestration of signaling motifs","volume":"188","author":"Jiang","year":"2025","journal-title":"Cell"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e202312141","DOI":"10.1083\/jcb.202312141","article-title":"Rapid turnover of CTLA4 is associated with a complex architecture of reversible ubiquitylation","volume":"224","author":"Tey","year":"2025","journal-title":"J Cell Biol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000039","article-title":"Overcoming T-cell exhaustion: New therapeutic targets in HCC immunotherapy","volume":"78","author":"Seimiya","year":"2023","journal-title":"Hepatology"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.112266","article-title":"CRISPR\/Cas9-mediated SHP-1-knockout T cells combined with simvastatin enhances anti-tumor activity in humanized-PDX HCC model","volume":"28","author":"Liu","year":"2025","journal-title":"iScience"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.7150\/thno.110567","article-title":"Short-term starvation inhibits CD36 N-glycosylation and downregulates USP7 UFMylation to alleviate RBPJ-maintained T cell exhaustion in liver cancer","volume":"15","author":"Pan","year":"2025","journal-title":"Theranostics"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.ado3485","article-title":"Riplet promotes lipid metabolism changes associated with CD8 T cell exhaustion and anti-PD-1 resistance in hepatocellular carcinoma","volume":"10","author":"Liang","year":"2025","journal-title":"Sci Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1790174","article-title":"Targeting the TIGIT\/CD155-induced metabolic checkpoint in NK cells restores anti-tumor immunity and suppresses hepatocellular carcinoma growth","volume":"17","author":"Jiaojie","year":"2026","journal-title":"Front Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"7836","DOI":"10.3390\/ijms26167836","article-title":"Immunological landscape and molecular therapeutic targets of the tumor microenvironment in hepatocellular carcinoma","volume":"26","author":"Zarlashat","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.115013","article-title":"The role of tumor-associated endothelial cells in Malignant progression and immune evasion of liver cancer","volume":"161","author":"Pu","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202413095","article-title":"Lactylation-driven NUPR1 promotes immunosuppression of tumor-infiltrating macrophages in hepatocellular carcinoma","volume":"12","author":"Jialiang","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B67","doi-asserted-by":"publisher","first-page":"980","DOI":"10.3390\/cancers18060980","article-title":"Overcoming MDSC-mediated immunosuppression in hepatocellular carcinoma: From mechanisms to novel immunotherapeutic approaches","volume":"18","author":"Yangzhi","year":"2026","journal-title":"Cancers (Basel)"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.273","article-title":"Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells","volume":"36","author":"Deng","year":"2017","journal-title":"Oncogene"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2025.02.002","article-title":"Overcoming immunotherapy resistance in hepatocellular carcinoma by targeting myeloid IL-8\/CXCR2 signaling","volume":"33","author":"Kwong","year":"2025","journal-title":"Mol Ther"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107626","article-title":"Myeloid-intrinsic cell cycle-related kinase drives immunosuppression to promote tumorigenesis","volume":"26","author":"Zhou","year":"2023","journal-title":"iScience"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102038","article-title":"ACVR2A attenuation impacts lactate production and hyperglycolytic conditions attracting regulatory T cells in hepatocellular carcinoma","volume":"6","author":"Yasukawa","year":"2025","journal-title":"Cell Rep Med"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2025.156219","article-title":"RBBP6-induced destabilization of FOXP3 promotes glucose metabolism and Malignant progression of HBV-related hepatocellular carcinoma","volume":"275","author":"Ge","year":"2025","journal-title":"Pathol Res Pract"},{"key":"B73","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41419-025-07738-2","article-title":"N-glycosylated LT\u03b2R increases the Th17\/Treg cell ratio in liver cancer by blocking RORC ubiquitination and FOXP3 transcription","volume":"16","author":"Pan","year":"2025","journal-title":"Cell Death Dis"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112534","article-title":"Activation of Wnt\/\u03b2-catenin signaling promotes immune evasion via the \u03b2-catenin\/IKZF1\/CCL5 axis in hepatocellular carcinoma","volume":"138","author":"Huang","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2026.105355","article-title":"Efferocytosis as a metabolic rheostat: The metabolic bridge connecting TKI-induced cell death to immune tolerance in hepatocellular carcinoma","volume":"223","author":"Xiyang","year":"2026","journal-title":"Crit Rev Oncol Hematol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-026-03711-1","article-title":"GPX8+ cancer-associated fibroblast-derived lactate contributes to lenvatinib resistance by facilitating BRPF1 expression through histone H3 lysine 18 lactylation in hepatocellular carcinoma","volume":"45","author":"Qinsi","year":"2026","journal-title":"Oncogene"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-026-09011-6","article-title":"AARS1-catalyzed H4K12 lactylation promotes HCC resistance to targeted therapy by activating RAPGEF3-RAP1 signaling","author":"Tanlun","year":"2026","journal-title":"Cell Death Dis"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2025-337331","article-title":"JOSD1 drives hepatocellular carcinoma Malignancy by modulating the ubiquitination-lactylation switch on PGAM1","author":"Qing","year":"2026","journal-title":"Gut"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1016\/j.cmet.2026.06.003","article-title":"AARS1 promotes tumor progression and immune evasion via ATF6 lactylation-mediated tryptophan metabolism in hepatocellular carcinoma","volume":"38","author":"Yiming","year":"2026","journal-title":"Cell Metab"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/j.cell.2016.11.022","article-title":"Tumor interferon signaling regulates a multigenic resistance program to immune checkpoint blockade","volume":"167","author":"Benci","year":"2016","journal-title":"Cell"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-021-00573-2","article-title":"Immunotherapies for hepatocellular carcinoma","volume":"19","author":"Llovet","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-24-3691","article-title":"JAB-3312, a potent allosteric SHP2 inhibitor that enhances the efficacy of RTK\/RAS\/MAPK and PD-1 blockade therapies","volume":"31","author":"Kang","year":"2025","journal-title":"Clin Cancer Res"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-023-02935-9","article-title":"TKT-PARP1 axis induces radioresistance by promoting DNA double-strand break repair in hepatocellular carcinoma","volume":"43","author":"Geng","year":"2024","journal-title":"Oncogene"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.105032","article-title":"PC4-mediated Ku complex PARylation facilitates NHEJ-dependent DNA damage repair","volume":"299","author":"Pan","year":"2023","journal-title":"J Biol Chem"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-026-03930-5","article-title":"O-GlcNAcylation of NONO mediates alternative splicing of SETMAR and facilitates NHEJ repair","volume":"27","author":"Mengyuan","year":"2026","journal-title":"Genome Biol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/s41392-025-02458-7","article-title":"KAT2A-driven succinylation of SRSF11 enforces spliceosome-mediated RAD52 splicing to promote homologous recombination and radioresistance in hepatocellular carcinoma","volume":"10","author":"Jun","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167481","article-title":"UBAP2 contributes to radioresistance by enhancing homologous recombination through SLC27A5 ubiquitination in hepatocellular carcinoma","volume":"1870","author":"Zijian","year":"2024","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B88","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.cell.2023.11.022","article-title":"Metabolic regulation of homologous recombination repair by MRE11 lactylation","volume":"187","author":"Chen","year":"2024","journal-title":"Cell"},{"key":"B89","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41420-026-03216-6","article-title":"Correction: A positive feedback loop between TKT and c-Myc drives TACE resistance in hepatocellular carcinoma","volume":"12","author":"Yifu","year":"2026","journal-title":"Cell Death Discov"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-025-01155-5","article-title":"SERPINA1 drives TACE resistance in hepatocellular carcinoma by competitively binding ITGB3 to block ITCH-mediated ubiquitination and degradation","volume":"49","author":"Liou","year":"2025","journal-title":"Cell Oncol (Dordr)"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-026-01802-w","article-title":"SUMOylation-stabilized G6PD orchestrates metabolic rewiring for oxidative stress survival and chemoresistance in HCC via a PKC\u03b4-phosphorylation trigger","author":"Hongliang","year":"2026","journal-title":"Cell Death Differ"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1009089","article-title":"Radiosensitization effect by HDAC inhibition improves NKG2D-dependent natural killer cytotoxicity in hepatocellular carcinoma","volume":"12","author":"Liu","year":"2022","journal-title":"Front Oncol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-025-01351-1","article-title":"Targeting MORF4L1-mediated DNA repair potentiates RT-induced antitumor immunity via cGAS-STING activation in hepatocellular carcinoma","volume":"22","author":"Si-Wei","year":"2026","journal-title":"Cell Mol Immunol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.2147\/JHC.S603485","article-title":"SPP1+ macrophages promote immunosuppression in post-TACE hepatocellular carcinoma involving lactate-induced lactylation and potential SPP1-CD44 signaling","volume":"13","author":"Hongyu","year":"2026","journal-title":"J Hepatocell Carcinoma"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1038\/ncb2629","article-title":"ERK1\/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect","volume":"14","author":"Weiwei","year":"2012","journal-title":"Nat Cell Biol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.577108","article-title":"PKM2-induced the phosphorylation of histone H3 contributes to EGF-mediated PD-L1 transcription in HCC","volume":"11","author":"Wang","year":"2020","journal-title":"Front Pharmacol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2019.12.010","article-title":"ATP citrate lyase: A central metabolic enzyme in cancer","volume":"471","author":"Icard","year":"2020","journal-title":"Cancer Lett"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-025-02869-z","article-title":"Hypoxia-induced USP13 expression drives ferroptosis resistance and tumor immune evasion in hepatocellular carcinoma through the stabilization of ACLY","volume":"12","author":"Kuan","year":"2025","journal-title":"Cell Death Discov"},{"key":"B99","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41419-024-06951-9","article-title":"Chemotherapy-induced acetylation of ACLY by NAT10 promotes its nuclear accumulation and acetyl-CoA production to drive chemoresistance in hepatocellular carcinoma","volume":"15","author":"Wang","year":"2024","journal-title":"Cell Death Dis"},{"key":"B100","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41419-022-04606-1","article-title":"Nanog mediated by FAO\/ACLY signaling induces cellular dormancy in colorectal cancer cells","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217978","article-title":"LGR5\/mTORC2 axis regulates cellular metabolic plasticity to maintain tumorigenesis in hepatocellular carcinoma","volume":"636","author":"Guishuai","year":"2026","journal-title":"Cancer Lett"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202412559","article-title":"Lactylation-driven HECTD2 limits the response of hepatocellular carcinoma to lenvatinib","volume":"12","author":"Dong","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.120165","article-title":"Hua Zheng San Ji Fang promotes ferroptosis through Keap1\/Nrf2 pathway in hepatocellular carcinoma cells","volume":"352","author":"Su","year":"2025","journal-title":"J Ethnopharmacol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156824","article-title":"Ponicidin promotes ferroptosis to enhance treatment sensitivity in lenvatinib-resistant hepatocellular carcinoma cells through regulation of KEAP1\/NRF2","volume":"143","author":"Zhang","year":"2025","journal-title":"Phytomedicine"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjz060","article-title":"p53 modifications: exquisite decorations of the powerful guardian","volume":"11","author":"Liu","year":"2019","journal-title":"J Mol Cell Biol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10616-026-00973-1","article-title":"Resveratrol coordinates apoptosis and autophagy in hepatocellular carcinoma cells via p53 acetylation: An integrative network pharmacology and experimental validation study","volume":"78","author":"Hui","year":"2027","journal-title":"Cytotechnology"},{"key":"B107","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13046-022-02288-3","article-title":"ZNF498 promotes hepatocellular carcinogenesis by suppressing p53-mediated apoptosis and ferroptosis via the attenuation of p53 Ser46 phosphorylation","volume":"41","author":"Zhang","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B108","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41420-026-03216-6","article-title":"Correction: A positive feedback loop between TKT and c-Myc drives TACE resistance in hepatocellular carcinoma","volume":"12","author":"Yifu","year":"2026","journal-title":"Cell Death Discov"},{"key":"B109","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41419-025-07663-4","article-title":"TTC36 promotes proliferation and drug resistance in hepatocellular carcinoma cells by inhibiting c-Myc degradation","volume":"16","author":"Fengling","year":"2025","journal-title":"Cell Death Dis"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.439","article-title":"Ubiquitin-specific protease 22 promotes tumorigenesis and progression by an FKBP12\/mTORC1\/autophagy positive feedback loop in hepatocellular carcinoma","volume":"4","author":"Ye","year":"2023","journal-title":"MedComm (2020)"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1177\/10732748241293680","article-title":"Exploring the impact of the \u03b2-catenin mutations in hepatocellular carcinoma: An in-depth review","volume":"31","author":"Alami","year":"2024","journal-title":"Cancer Control"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-0111-4","article-title":"Silencing MYH9 blocks HBx-induced GSK3\u03b2 ubiquitination and degradation to inhibit tumor stemness in hepatocellular carcinoma","volume":"5","author":"Lin","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5483\/bmbrep.2017.50.1.196","article-title":"Interacting network of Hippo, Wnt\/\u03b2-catenin and Notch signaling represses liver tumor formation","volume":"50","author":"Kim","year":"2017","journal-title":"BMB Rep"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.11885","article-title":"Restoring miR122 in human stem-like hepatocarcinoma cells, prompts tumor dormancy through Smad-independent TGF-\u03b2 pathway","volume":"7","author":"Boix","year":"2016","journal-title":"Oncotarget"},{"key":"B115","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/s41419-025-07887-4","article-title":"Inhibition of the Caveolin-1 pathway promotes apoptosis and overcomes pan-tyrosine kinase inhibitor resistance in hepatocellular carcinoma","volume":"16","author":"Kabir","year":"2025","journal-title":"Cell Death Dis"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2407904121","article-title":"WDR20 prevents hepatocellular carcinoma senescence by orchestrating the simultaneous USP12\/46-mediated deubiquitination of c-Myc","volume":"121","author":"Li","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"key":"B117","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13148-025-01838-8","article-title":"Novel histone modifications and liver cancer: emerging frontiers in epigenetic regulation","volume":"17","author":"Wang","year":"2025","journal-title":"Clin Epigenet"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-015-4707-1","article-title":"MK2206 overcomes the resistance of human liver cancer stem cells to sorafenib by inhibition of pAkt and upregulation of pERK","volume":"37","author":"Zhai","year":"2016","journal-title":"Tumour Biol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky589","article-title":"Loss of tumor suppressor IGFBP4 drives epigenetic reprogramming in hepatic carcinogenesis","volume":"46","author":"Lee","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"B120","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/s41419-024-07198-0","article-title":"Integration of epigenomic and transcriptomic profiling uncovers EZH2 target genes linked to cysteine metabolism in hepatocellular carcinoma","volume":"15","author":"Jaehyun","year":"2024","journal-title":"Cell Death Dis"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1111\/cas.16186","article-title":"EZH2 suppresses ferroptosis in hepatocellular carcinoma and reduces sorafenib sensitivity through epigenetic regulation of TFR2","volume":"115","author":"Lai","year":"2024","journal-title":"Cancer Sci"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.521","article-title":"LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells","volume":"36","author":"Xiong","year":"2017","journal-title":"Oncogene"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202304263","article-title":"BRCC36 deubiquitinates HMGCR to regulate the interplay between ferroptosis and pyroptosis","volume":"11","author":"Haiyan","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.853652","article-title":"AZD5153, a bivalent BRD4 inhibitor, suppresses hepatocarcinogenesis by altering BRD4 chromosomal landscape and modulating the transcriptome of HCC cells","volume":"10","author":"Lin","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygeno.2021.02.017","article-title":"Multi-omics characterization of WNT pathway reactivation to ameliorate BET inhibitor resistance in liver cancer cells","volume":"113","author":"Liu","year":"2021","journal-title":"Genomics"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29328","article-title":"Targeting histone deacetylase 4\/ubiquitin-conjugating enzyme 9 impairs DNA repair for radiosensitization of hepatocellular carcinoma cells in mice","volume":"67","author":"Tsai","year":"2018","journal-title":"Hepatology"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-603","article-title":"PARP inhibition and the radiosensitizing effects of the PARP inhibitor ABT-888 in in vitro hepatocellular carcinoma models","volume":"14","author":"Guillot","year":"2014","journal-title":"BMC Cancer"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2011.12.022","article-title":"Radiosensitizing effect of a phenylbutyrate-derived histone deacetylase inhibitor in hepatocellular carcinoma","volume":"83","author":"Lu","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70504","article-title":"Yin Yang 1 promotes antiprogrammed cell death-1 resistance in hepatocellular carcinoma through polypeptide N-acetylgalactosaminyltransferase 16-mediated glycosylation of programmed death ligand-1","volume":"6","author":"Shu-Sheng","year":"2025","journal-title":"MedComm (2020)"},{"key":"B130","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s12672-026-05152-4","article-title":"A tumor microenvironment-focused signature based on m6A and lactylation modification predicts prognosis and immunotherapy response in hepatocellular carcinoma","volume":"17","author":"Shaohui","year":"2026","journal-title":"Discov Oncol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s12935-025-03964-y","article-title":"Integrating bulk RNA-seq, scRNA-seq, and spatial transcriptomics data to identify novel post-translational modification-related molecular subtypes and therapeutic responses in hepatocellular carcinoma","volume":"25","author":"Shiling","year":"2025","journal-title":"Cancer Cell Int"},{"key":"B132","doi-asserted-by":"publisher","first-page":"e012979","DOI":"10.1136\/jitc-2025-012979","article-title":"NX-1607: lifting the Cbl-b brake to promote T cell activation through MAPK\/ERK pathways","volume":"13","author":"Alex","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-15-0976","article-title":"Single agent and synergistic activity of the \"First-in-Class\" dual PI3K\/BRD4 inhibitor SF1126 with sorafenib in hepatocellular carcinoma","volume":"15","author":"Singh","year":"2016","journal-title":"Mol Cancer Ther"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113889","article-title":"Synergistic blockade of SHP-2 and A2AR signal pathways with targeted nanoparticles restores anti-tumor immunity of CD8+ T cells","volume":"384","author":"Mingshui","year":"2025","journal-title":"J Control Release"}],"updated-by":[{"DOI":"10.3389\/fimmu.2026.1986779","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000}}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1914652\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:03:10Z","timestamp":1789729390000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1914652\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":134,"alternative-id":["10.3389\/fimmu.2026.1914652"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1914652","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"article-number":"1914652"}}